BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26617805)

  • 1. MiR-19a targets suppressor of cytokine signaling 1 to modulate the progression of neuropathic pain.
    Wang C; Jiang Q; Wang M; Li D
    Int J Clin Exp Pathol; 2015; 8(9):10901-7. PubMed ID: 26617805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway.
    Tan Y; Yang J; Xiang K; Tan Q; Guo Q
    Neurochem Res; 2015 Mar; 40(3):550-60. PubMed ID: 25488154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MicroRNA-221 Alleviates Neuropathic Pain Through Targeting Suppressor of Cytokine Signaling 1.
    Xia L; Zhang Y; Dong T
    J Mol Neurosci; 2016 Jul; 59(3):411-20. PubMed ID: 27059231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-155 modulates the progression of neuropathic pain through targeting SGK3.
    Liu S; Zhu B; Sun Y; Xie X
    Int J Clin Exp Pathol; 2015; 8(11):14374-82. PubMed ID: 26823753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA-218 relieves neuropathic pain by regulating suppressor of cytokine signaling 3.
    Li L; Zhao G
    Int J Mol Med; 2016 Mar; 37(3):851-8. PubMed ID: 26782075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats.
    Xue ZJ; Shen L; Wang ZY; Hui SY; Huang YG; Ma C
    Brain Res; 2014 Oct; 1583():79-88. PubMed ID: 25084036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of microRNA-19a-3p alleviates the neuropathic pain (NP) in rats after chronic constriction injury (CCI) via targeting KLF7.
    Wang X; Pang J; Cui J; Liu A; Wang H
    Transpl Immunol; 2023 Feb; 76():101735. PubMed ID: 36334791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-202 modulates the progression of neuropathic pain through targeting RAP1A.
    Fang B; Wei L; Dong K; Niu X; Sui X; Zhang H
    J Cell Biochem; 2019 Mar; 120(3):2973-2982. PubMed ID: 30520098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-145 ameliorates neuropathic pain via inhibiting inflammatory responses and mTOR signaling pathway by targeting Akt3 in a rat model.
    Shi J; Jiang K; Li Z
    Neurosci Res; 2018 Sep; 134():10-17. PubMed ID: 29162479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-19a promotes cell growth and tumorigenesis through targeting SOCS1 in gastric cancer.
    Qin S; Ai F; Ji WF; Rao W; Zhang HC; Yao WJ
    Asian Pac J Cancer Prev; 2013; 14(2):835-40. PubMed ID: 23621248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal miR-183 delivery suppresses mechanical allodynia in mononeuropathic rats.
    Lin CR; Chen KH; Yang CH; Huang HW; Sheen-Chen SM
    Eur J Neurosci; 2014 May; 39(10):1682-9. PubMed ID: 24612023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of miR-206 ameliorates chronic constriction injury-induced neuropathic pain in rats via the MEK/ERK pathway by targeting brain-derived neurotrophic factor.
    Sun W; Zhang L; Li R
    Neurosci Lett; 2017 Apr; 646():68-74. PubMed ID: 28130187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of microRNA-34c-5p alleviates neuropathic pain via the SIRT1/STAT3 signaling pathway in rat models of chronic constriction injury of sciatic nerve.
    Mo Y; Liu B; Qiu S; Wang X; Zhong L; Han X; Mi F
    J Neurochem; 2020 Aug; 154(3):301-315. PubMed ID: 32126145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-203 involves in neuropathic pain development and represses Rap1a expression in nerve growth factor differentiated neuronal PC12 cells.
    Li H; Huang Y; Ma C; Yu X; Zhang Z; Shen L
    Clin J Pain; 2015 Jan; 31(1):36-43. PubMed ID: 24451631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNHG16 aggravates chronic constriction injury-induced neuropathic pain in rats via binding with miR-124-3p and miR-141-3p to upregulate JAG1.
    Li H; Fan L; Zhang Y; Cao Y; Liu X
    Brain Res Bull; 2020 Dec; 165():228-237. PubMed ID: 33049352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YY1 promotes SOCS3 expression to inhibit STAT3‑mediated neuroinflammation and neuropathic pain.
    Sun M; Sun Y; Ma J; Li K
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00657 expedites neuropathic pain development by modulating miR-136/ZEB1 axis in a rat model.
    Shen F; Zheng H; Zhou L; Li W; Zhang Y; Xu X
    J Cell Biochem; 2019 Jan; 120(1):1000-1010. PubMed ID: 30203524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of XIST/miR-137 axis on neuropathic pain by targeting TNFAIP1 in a rat model.
    Zhao Y; Li S; Xia N; Shi Y; Zhao CM
    J Cell Physiol; 2018 May; 233(5):4307-4316. PubMed ID: 29115665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1.
    Li A; Song W; Qian J; Li Y; He J; Zhang Q; Li W; Zhai A; Kao W; Hu Y; Li H; Wu J; Ling H; Zhong Z; Zhang F
    Int J Biochem Cell Biol; 2013 Apr; 45(4):858-65. PubMed ID: 23348614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-384-5p ameliorates neuropathic pain by targeting SCN3A in a rat model of chronic constriction injury.
    Ye G; Zhang Y; Zhao J; Chen Y; Kong L; Sheng C; Yuan L
    Neurol Res; 2020 Apr; 42(4):299-307. PubMed ID: 32098588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.